Serum tyrosine hydroxylase activity is increased in melanoma patients. An ROC curve analysis.
We have studied the serum tyrosine hydroxylase activity of tyrosinase, the key enzyme in the melanogenesis via, as a possible diagnostic factor or marker for detection, prognosis and follow-up of patients with melanoma. This activity was determined in 30 melanoma patients (MP) and in 30 healthy persons (HP) by using a radiometric method. We found mean values of 10.8+/-3.0 and 7.65+/-2.32 mU/l for serum tyrosine hydroxylase activity in MP and HP, respectively. A very significant increase in serum tyrosine hydroxylase activity was observed in MP in comparison to the enzymatic activity in HP (P < 0.00001). Although these data seem very conclusive, we wanted to know whether this test could discriminate adequately between MP and HP. In order to reach this aim, a complete statistical study was performed by using receiver operating characteristic (ROC) curve analysis. The cut-off value obtained was 8.47 mU/l. According to our results and after analytical treatment of the data, we can confirm that evaluation of tyrosine hydroxylase activity in serum could be a quick and reliable diagnostic method for detection, prognosis and follow-up in melanoma patients.
Ros-Bullón
M R
MR
Division of Clinical Analysis, H.U.V. Arrixaca, Murcia, Spain.
Sánchez-Pedreño
P
P
Martínez-Liarte
J H
JH
D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D008545:Melanoma / Q000097:blood* / Q000175:diagnosis / Q000201:enzymology; D011379:Prognosis; D012372:ROC Curve; D014446:Tyrosine 3-Monooxygenase / Q000097:blood*
D014408:Biomarkers, Tumor; D014446:Tyrosine 3-Monooxygenase